Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03753282

Outcome After Avascular Necrosis of the Femoral Head in Young Patients

Outcome After Avascular Necrosis of the Femoral Head in Young Patients - Retrospective Analysis With a Min. 10-year Follow-up

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

1. The course of AVN between Initial diagnosis and total hip replacement (THA) is analysed. The impact of early interventions versus conservative therapy in AVN before THA will be evaluated. 2. The short and long term outcomes of AVN patients undergoing THA with respect to complications, reoperations and quality of life are investigated. Potential risk factors for adverse outcomes will be investigated.

Detailed description

The study is to describe the course of avascular necrosis (AVN) of the femoral head from initial diagnosis and to collect data on treatment options and the further course in these cases. The duration from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) will be analysed and the course after joint replacement with potential short- and long-term complications will be evaluated. The impact of THA after AVN on activities of daily living will be assessed by Euroquol 5 Dimensions (EQ-5D-5L) and Hip disability and Osteoarthritis Outcome Score (HOOS) questionnaires.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaires for patient reported outcomequestionnaires with respect to outcomes: * Reoperations * Short term complications * Long term complications * EQ-5D (current) * HOOS (current) * disease related change of occupation * use of walking aids * comorbidities * medication
OTHERquestionnaire for course of the diseasequestionnaires to assess course of the disease: * from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) * therapeutic interventions

Timeline

Start date
2019-01-30
Primary completion
2019-03-05
Completion
2019-03-05
First posted
2018-11-26
Last updated
2019-03-29

Source: ClinicalTrials.gov record NCT03753282. Inclusion in this directory is not an endorsement.